國家衛生研究院 NHRI:Item 3990099045/11725
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 907639      Online Users : 967
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/11725


    Title: Targeting RSPO3 reduces stem cell function in RSPO3-Fusion-positive colon cancer and RSPO3 high lung cancer
    Authors: Hsu, J;Hung, HC;Yen, WC;Chang, TY;Yen, GJ;Huang, CT;Fnag, MY;Lai, YL;Tsai, YR;Chen, CT;Shih, JC;Hsu, JTA
    Contributors: Institute of Biotechnology and Pharmaceutical Research
    Abstract: Recent studies have revealed that the R-spondins (RSPOs) can mediate with Lgr4 and Lgr5 proteins/Frizzled/LRP receptor complexes as an independent (noncanonical) control of the Wnt pathway. Several lines of evidence supported that RSPOs play a positive role in the regulation of Wnt/beta-catenin signalling. We have identified an anti-RSPO3 antibody (DBPR117; hB1) using a rational design approach. DBPR117 was identified as an ideal candidate to be developed as a therapeutic antibody. DBPR117 was well characterized in a variety of assays including the binding assays, in vitro bioassays, in vivo PDX (patient-derived xenograft), lung cancer or colon cancer CDX (cell line-derived xenograft) models. DBPR117 is capable of binding specifically to the human RSPO3 with novel amino acid sequences in the complementary determining regions (CDRs). DBPR117 showed efficacy in human colon and lung cancers with RSPO3 fusion/overexpression. We are currently evaluating whether antagonizing RSPO3 by DBPR117 would synergize with anti-PD-L1 antibody to combat cancers using syngeneic murine models.
    Date: 2018-12
    Relation: Cancer Science. 2018 Dec;109(SI, Suppl. 2):210.
    Link to: https://doi.org/10.1111/cas.13904
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1347-9032&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000453773601015
    Appears in Collections:[John Tsu-An Hsu] Conference Papers/Meeting Abstract
    [Chiung-Tong Chen] Conference Papers/Meeting Abstract
    [Chuan Shih(2014-2017)] Conference Papers/Meeting Abstract
    [Wan-Ching Yen] Conference Papers/Meeting Abstract

    Files in This Item:

    File SizeFormat
    ISI000453773601015.pdf35KbAdobe PDF327View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback